← All trials
NCT03958383
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2019
- Primary completion
- Jul 15, 2024
- Completion date
- Jul 15, 2025
- First posted
- —
- Last posted
- —
- Enrollment
- 61
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of WisconsinLead sponsor
- National Cancer Institute (NCI)Collaborator
- Provenance BiopharmaceuticalsCollaborator
- University of WisconsinOverall official - principal investigator
- University of WisconsinStudy chair
- Bristol-Myers SquibbCollaborator
- University of WisconsinOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.